It has been shown that higher YTHDF1 and YTHDF3 expressions were correlated with a shorter survival in breast cancer (BC) (39), and the importance of YTHDF3 as an independent risk factor for BC has been a topic of significant research. Here, YTHDF3 is linked to breast cancer.